Pasi, S., Kant, R., & Surolia, A. (2016). Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response. J Biol Chem.
Chicago ZitierstilPasi, Shweta, Ravi Kant, und Avadhesha Surolia. "Toll/Interleukin-1 Receptor Domain Derived From TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis By Down-modulating Th17 Cell Response." J Biol Chem 2016.
MLA ZitierstilPasi, Shweta, Ravi Kant, und Avadhesha Surolia. "Toll/Interleukin-1 Receptor Domain Derived From TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis By Down-modulating Th17 Cell Response." J Biol Chem 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.